Triple
T607371
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Menlo Park, California |
E12023
|
entity |
| Predicate | hostsCompanyOffices |
P9342
|
FINISHED |
| Object |
Pacific Biosciences
Pacific Biosciences is a biotechnology company specializing in advanced DNA sequencing technologies, particularly long-read sequencing platforms used in genomics research.
|
E75827
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Pacific Biosciences | Statement: [Menlo Park, California, hostsCompanyOffices, Pacific Biosciences]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Pacific Biosciences Context triple: [Menlo Park, California, hostsCompanyOffices, Pacific Biosciences]
-
A.
Agilent Technologies
Agilent Technologies is a global company specializing in life sciences, diagnostics, and analytical laboratory instruments and services.
-
B.
Danaher Corporation
Danaher Corporation is a diversified global science and technology conglomerate known for its portfolio of life sciences, diagnostics, and industrial solutions businesses.
-
C.
Broad Institute of MIT and Harvard
The Broad Institute of MIT and Harvard is a leading biomedical and genomic research center known for large-scale collaborative projects that advance understanding of human disease and inform new therapies.
-
D.
Samsung Biologics
Samsung Biologics is a South Korean biopharmaceutical company specializing in contract development and manufacturing (CDMO) of biologic drugs for global pharmaceutical and biotech firms.
-
E.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Pacific Biosciences Triple: [Menlo Park, California, hostsCompanyOffices, Pacific Biosciences]
Generated description
Pacific Biosciences is a biotechnology company specializing in advanced DNA sequencing technologies, particularly long-read sequencing platforms used in genomics research.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Pacific Biosciences Target entity description: Pacific Biosciences is a biotechnology company specializing in advanced DNA sequencing technologies, particularly long-read sequencing platforms used in genomics research.
-
A.
Agilent Technologies
Agilent Technologies is a global company specializing in life sciences, diagnostics, and analytical laboratory instruments and services.
-
B.
Danaher Corporation
Danaher Corporation is a diversified global science and technology conglomerate known for its portfolio of life sciences, diagnostics, and industrial solutions businesses.
-
C.
Broad Institute of MIT and Harvard
The Broad Institute of MIT and Harvard is a leading biomedical and genomic research center known for large-scale collaborative projects that advance understanding of human disease and inform new therapies.
-
D.
Samsung Biologics
Samsung Biologics is a South Korean biopharmaceutical company specializing in contract development and manufacturing (CDMO) of biologic drugs for global pharmaceutical and biotech firms.
-
E.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a493309df48190a327f748e88049a6 |
completed | March 1, 2026, 7:27 p.m. |
| NER | Named-entity recognition | batch_69a4a514b514819088e7b6b7e4675905 |
completed | March 1, 2026, 8:44 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a52925321c8190a0d1df7a58096c4e |
completed | March 2, 2026, 6:07 a.m. |
| NEDg | Description generation | batch_69a529ffc0cc8190b42f4bde8860deeb |
completed | March 2, 2026, 6:11 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69a52a4d52f08190b79b290372da94b3 |
completed | March 2, 2026, 6:12 a.m. |
Created at: March 1, 2026, 7:35 p.m.